Guangdong Jiabo Pharmaceutical Co., Ltd. (hereinafter referred to as Jiabo pharmaceutical), founded in 2003, is an innovative high-tech pharmaceutical enterprise integrating R & D, production and sales, and focusing on perioperative fields and special injections. He has been deeply engaged in the field of anesthesia for many years. He is one of the main enterprises producing "propofol" anesthetics in China. He is the national quality standard setter of "propofol emulsion injection", the pharmaceutical enterprise with the most investment value in China, the scientific and technological innovation pharmaceutical enterprise with the most growth potential in China, the national intellectual property advantage enterprise, and the national advanced private enterprise in employment and social security.
Now it has a technical R & D team composed of professional researchers, doctors and masters. In recent years, the R & D center has actively carried out independent R & D projects, participated in and undertaken a number of national, provincial and municipal science and technology projects, owned a number of authorized invention patents and utility model patents, and won the honorary title of China Patent Award. Relying on the R & D center, the company actively carries out foreign cooperation, and has successively established technology platforms such as the production, study and research base of Sun Yat sen University, Guangdong intravenous fat emulsion engineering technology research center and Guangdong postdoctoral innovation practice base, so as to improve the R & D and innovation ability of the company and promote the high-quality development of the enterprise.
The company's product line layout is perfect. It has many GMP production lines such as small capacity, large capacity injection, sterile small capacity, soft bag line and API, as well as production lines in line with EU standards (to be certified), which can meet the industrialized production of various complex injections. At present, the reserve of R & D pipeline is sufficient, there are many potential varieties ready to go, and the production technology and related quality control technology of complex injections such as liposome and fat emulsion are at the domestic advanced level.
The products produced by Jiabo pharmaceutical are safe and effective, can meet the domestic clinical needs, and the sales volume increases steadily year by year. According to the enterprise development strategy, actively explore foreign markets. The company's products have been exported to Europe, South America, North America, Africa and other countries and regions, which has laid a solid foundation for the sustainable development of the enterprise in the future.
